The Effect of Low-Level Laser Therapy in Carpal Tunnel Syndrome
- Disease/Condition
- Carpal Tunnel Syndrome
- Drug/Device/Intervention
- treatment with low-level laser therapy
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Medical University of Graz
- Location
- Graz, Austria
- Phase
- N/A
- Start date
- Aug 03, 2023
- End date
- Dec 31, 2025
- Enrollment
- 40 participants
Pain: at rest (Numerical Rating Scale for Pain, NRS),Pain:movement pain (Numerical Rating Scale for Pain, NRS),Pain: Night pain (Numerical Rating Scale for Pain, NRS),Health-related quality of ife (SF-36 ),Hand function (Quick-DASH),Hand function and CTS severity (Boston CTS Syndrome Questionnaire)
Carpal tunnel syndrome (CTS) is a chronic compression of the median nerve, which can lead to
 symptoms such as nocturnal pain and paresthesia in the area innervated by the median nerve.
 The affected patients also describe discomfort and hypoesthesia in the nerve supply area. Due
 to the COVID (Coronavirus disease) pandemic, CTS operations have been postponed and delayed.
 A promising and safe alternative for improving CTS-related symptoms appears to be
 non-invasive, non-thermal low-level-laser therapy. As a possible conservative, alternative
 method, low-level-laser therapy has the potential to enable patients with CTS to improve
 their disease-related symptoms or at least to alleviate the symptoms until the indicated CTS
 operation (carpal tunnel release).
 
 The aim of this randomized, single-blind, placebo-controlled clinical trial is to investigate
 the influence of 3 weeks of low-level-laser therapy on the symptoms typical of CTS in
 patients with surgery-indicated carpal tunnel syndrome and its influence on quality of life.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06248541
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06248541 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Graz and is currently Recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.